L-selectin is down-modulated from the cell surface in response to leukocyte activation or cross-linking with ligand mimetics such as anti-L-selectin antibodies or sulfatides. The down-modulation induced upon cellular activation with PMA is due to proteolytic shedding mediated by a cysteine metalloprotease, presumably the TNF-a converting enzyme (TACE), and is susceptible to inhibitors of the hydroxamate class. To determine if cross-linking-induced down-modulation of L-selectin is similarly affected by these inhibitors, we exposed Jurkat T cells to the anti-Lvselectin antibody Dreg 200 or sulfatides in the presence of the hydroxamate TNF-a protease inhibitor (TAPI). TAPI completely inhibited PMA-induced downmodulation but had no effect on that induced by the anti-L-selectin antibody or sulfatides. The downmodulation induced by an anti-TCR antibody (WT31) was only partially inhibited by TAPI. An L-selectin mutant lacking the putative TACE cleavage site and resistant to PMA-induced shedding (321deI.9) was expressed in L1.2 pre-B cells. Like WT L-selectin, this mutant was down-modulated when exposed to sulfatides, or Dreg 200 and this down-modulation was unaffected by TAPI. An L-selectin cytoplasmic tail deletion mutant (344deI.15) expressed in L1.2 pre-B cells was down-modulated by PMA or sulfatides, but not Dreg 200. Electrophoretic analysis ofL-selectin immunoprecipitated from the supernatants of Jurkat cells treated with either sulfatides or D200 revealed a proteolytic fragment of the same size as that released from the cell surface in response to PMA. Our data indicate that the down regulation of L-selectin in response to cross-linking by ligands or TCR engagement may be mechanistically distinct from that induced by PMA. Furthermore, our results with the 344de1.15 mutant suggest that the down-modulation of Lselectin induced by certain sulfated carbohydrate ligands may be initiated through surface receptors other than L-selectin itself.
conformation in activated leukocytes, L-selectin is down-modulated from the cell surface in response to leukocyte activation or ligand engagement (7, 8) . In the case of PMA-induced activation, this loss of L-selectin is due to the action of an exoprotease, most likely the TNF-a converting enzyme (TACE) , that cleaves the molecule between Lys32l and Ser322, resulting in the shedding of nearly the entire extracellular domain (9) .
The biological significance of L-selectin shedding is presently unclear. Several lines of evidence suggest that the shed fragment may regulate the intensity of an inflammatory reaction by competing with the cell-associated selectin for endothelial ligands, thereby interfering with leukocyte rolling. For example, the injection of a soluble L-selectin-IgG chimera reduced the number of neutrophils migrating into the peritoneum of mice with thioglycollate-induced peritonitis (10) . In another study, soluble L-selectin purified from leukemic plasma completely inhibited the adhesion of lymphoblasts to TNF-activated endothelium in vitro (11) . However, despite these observations, it remains unclear whether physiologic concentrations of the shed fragment significantly modulate leukocyte-endothelial interactions in vivo.
Ligand engagement ofL-selectin is sufficient to acti vate [31 and [32 integrin-dependent leukocyte adhesion to fibronectin and ICAM -1, respectively, in the absence of exogenous chemokines or other stimuli (12) (13) (14) . It is therefore reasonable to propose that L-selectin may playa similar regulatory role in integrin-dependent adhesion to the endothelium in vivo. It is also possible that the down-modulation ofL-selectin induced by ligand engagement may limit the duration and intensity of these integrin-dependent adhesive interactions and that the loss ofL-selectin from the cell surface may be essential for leukocyte detachment from the endothelium during transmigration. This hypothesis has, in fact, been explored by several investigators with somewhat conflicting results. In one study, the hydroxamate TACE inhibitor KD-IX-73-4 was shown to reduce the velocity of neutrophil rolling on peripheral lymph node addressin affinity-purified from inflamed human tonsils ( 15) . In another study using the hydroxamate R031-9790, neutrophil attachment, rolling, and transmigration through activated endothelial cell monolayers were all shown to be independent of L-selectin shedding (16) . In more recent studies, the effect of L-selectin shedding on leukocyte rolling velocity was found to depend on whether or not the endothelium expressed E-selectin (17) . The role of L-selectin shedding in lymphocyte homing and re-circulation is even less well characterized and may be different than that reported for leukocyte adhesion to inflamed endothelium.
We previously demonstrated that the deletion of a nine-residue sequence from the membrane proximal domain of L-selectin rendered the molecule resistant to PMA-induced shedding i18). Mutants lacking this sequence, however, could be down-modulated by antibody cross-linking, suggesting that ligand-induced down-modulation was likel y to proceed through a mechanism distinct from that activated by PMA. In our studies reported herein, we evaluated the effects of a hydroxamate TNF-a protease inhibitor (TAPI) on the down-modulation of wild type and mutant L-selectins induced by specific antibodies and Lselectin ligand mimetics. These studies demonstrated that ligand-induced downmodulation of L-selectin is a proteolytic event that is unaffected by either TAPI or the deletion of residues at the TACE cleavage site. This failure to maintain L-selectin surface expression in the presence ofligands suggests that there may be limitations in the use ofhydroxamate inhibitors and PMA-resistant L-selectin mutants in studies designed to assess the role of L-selectin downmodulation in ligand-dependent processes such as lymphocyte homing.
MATERIALS AND METHODS

Reagents and monoclonal antibodies
Sulfatides and 4[3-phorboI12-myristate I3-acetate (PMA) were purchased from Sigma (St. Louis, MO). The TNF-a protease inhibitor (TAPI) was a gift of R. Black (Immunex, Seattle, WA). The Lsselectin mAbs Dreg 200, Dreg 55 and Dreg 56 were obtained from Endogen (Woburn, MA), the L-selectin polyclonal Ab, N-18, was purchased from Santa Cruz Biotechnology (Santa Cruz, CA) and the PE-conjugated L-selectin mAb Leu-8 was obtained from Becton Dickinson (San Jose, CA). The TCR a/[3 mAb WT3I was purchased from Becton Dickinson (San Jose, CA).
Construction ofL-selectin mutants by site-directed mutagenesis
The wild-type human L-selectin cDNA was provided by Dr. T. Tedder (Duke University, Durham, NC) (19) . The construction and subcloning of the WT L-selectin and 321de1.9 and 344de1.15 mutant L-selectin cDNAs have been previously described (18) . The 344de1.15 mutant L-selectin was subcloned from the CDM8 vector into the pCDNA3 vector for improved expression in transient transfections.
Cell lines and transfections
The murine pre-B cell line L1.2 was stably transfected with the WT and 321de1.9L-selectin cDNAs as previously described (18) . Briefly, L1.2 cells were co-transfected with 25 J.1g L-selectin cDNA (or CDM8 only) and 2.5 J.1g pHSVNEO. Four million cells were electroporated in 0.5 ml RPMI 164011 % FBS at 270 V and 960 uF using a Gene Pulsar electroporator (BioRad, Hercules, CA). L1.2 cells were maintained in RPMI 1640 containing 10% FBS, 50 IV/ml penicillin and 50 J.1g/ml streptomycin for 72 hours and the medium was then changed to include 500 u.g/rnl (active concentration) geneticin (Life Technologies, Grand Island, NY). Transfectants were selected in geneticincontaining medium for 18-24 days, after which cells were analyzed for L-selectin expression by flow cytometry. L1.2 cells expressing the L-selectin cytoplasmic tail deletion mutant (344de1.15) were generated by transient transfection. Cells were cultured at a density of2x1Os cells/ml the day prior to transfection. On the day of the transfection, cells were washed in PBS and resuspended at a density of 8.5x10 s cells/well in 1.5 ml complete medium in 12 well plates. Cells were transfected with 1.25 J.1g of 344del.15 in pCDNA3 (or vector alone) using Superfect transfection reagent (Qiagen, Valencia, CA) according to the protocol provided. Thirty six to forty hours after following transfection, cells were harvested for study.
Preparation of antibody coated plates
For antibody cross-linking studies, 96 well plates (Linbro, Titertek) were coated with 10 p.g/rnl antibody overnight at 4°C and then blocked with 2% BSA for 1 hour at 37°C. The wells were then washed three times with PBS before the addition of cells.
Induction of L-selectin down-modulation
Jurkat T cells or L1.2 transfectants were washed in PBS and resuspended in RPMII15 mM HEPES/0.2% BSA. The cells were then treated with 25 nM TAPI in DMSO or DMSO alone at 37°C for 15 minutes and then exposed to PMA, sulfatides or immobilized antibody in 96 well plates for 1 hour at a density of 5x 10 4 cellsl1 00 J.11 in triplicates. The 96 well plate was then cooled on ice before preparation of the cells for flow cytometry.
Flow cytometry
Cells were washed once in staining buffer (PBS/ 0.1 % BSA/0.01 % sodium azide) and then stained with FITC-conjugated anti-L-selectin mAb Dreg 56 (5 J.1g/ ml) or PE-conjugated L-selectin mAb Leu-8 (5 ug/ml) for 30 minutes on ice. The cells were then washed once in staining buffer and resuspended in staining buffer containing 0.5 mg/ml propidium iodide. The cells were analyzed for mean fluorescence intensity using a flow cytometer (FACScan, Becton Dickinson, San Jose, CA) with Cellquest software (Becton Dickinson, San Jose, CA). Dead cells (propidium iodide stained) were excluded from the final analysis.
[35S]-cysteine/methionine metabolic labeling and immunoprecipitation of L-selectin
Jurkat cells (2xl0 7 ) were washed once in PBS and then washed again in serum-free, cysteine/methioninefree medium (Biowhittaker, Wakesfield, MA). To deplete intracellular cysteine and methionine stores, the cells were resuspended in the same medium at 37°C for 20 minutes, washed and then resuspended in 2.5 mls of cysteine/methionine-free RPMI containing 10% serum. To each 2.5-ml volume of 2x10 7 Jurkat cells, 1000 J.1Ci (400 J.1Ci/ml) of [3SS]-cysteine/methionine (New England Nuclear, Boston, MA) was added and the cells were then incubated at 37°C for 5 hours. The cells were then left untreated (control), or treated with PMA (50 ng/ml), sulfatides (100 u.g/ml) or L-selectin mAb D200 (25 ug/ml) for 60 minutes. Cells and supernatants were then separated by centrifugation at 400xg for 10 minutes at 4°C. Cell lysates were prepared by resuspending the cells in 1.0 ml of RIPA buffer (150 mM NaCl, 50 mM Tris pH 7.4, 1.0% triton X-I 00) containing protease inhibitors (2 ug/mlleupeptin, 100 ug/ml PMSF) and incubating for 30 minutes on ice. Cell lysates were clarified by centrifugation (l3,000xg for 20 minutes) at 4°C. Supernatants were spun a second time (13,000xg for 10 minutes) to remove cell debris and protease inhibitors (2 ug/ml leupeprln, 100 ug/ml PMSF) and 1.0 % triton X-IOO were added. Lysates and supernatants were then incubated overnight at 4°C with a mixture of anti-L-selectin Abs (mAbs Dreg 55 and Dreg 56 and a polyclonal antibody N-18, all at 1 ug/ml). Recombinant protein G-sepharose was then added to each lysate or supernatant and incubated at 4°C for 60 minutes. The immunoprecipitates were washed 3 times with RIPA buffer and then 3 more times with NaHP0 4 buffer (20 mM NaHP0 4 , 500 mM NaC!, 0.1 % SDS, 1% NP-40, 0.5% deoxycholate, 0.02% NaN3, pH 7.5). The washed immunoprecipitates were then resuspended in 5X loading buffer (250 mM Tris pH 6.8, 10% SDS, 10% glycerol, 0.1 % bromophenol blue dye and 5% 2iimercaptoethanol) and boiled for 10 minutes. The reduced samples were then fractionated by SDS-PAGE (l 0%). The gels were dried, and processed for autoradiography at -70°C.
RESULTS
Effect ofTAPI on L-selectin down-modulation
To determine if hydroxamate inhibitors are able to inhibit L-selectin down-modulation induced by cross-linking, Jurkat T cells were exposed to PMA (50 p.g/ml), sulfatides (10 p.g/ml), immobilized anti-L-selectin mAb (Dreg 200 at 10 p.g/ml), or an immobilized anti-TCR mAb (WT31 at 10 u.g/ml) for 1 hour in the presence or absence ofTAPI (25 nM selectin expression using the non-cross reactive FITC-conjugated anti-L-selectin mAb Dreg 56. As shown in Figure 1 , TAPI completely inhibited PMA-induced down-modulation but had no effect on that induced by an anti-L-selectin mAb or sulfatides and only a modest effect on the downmodulation induced by the anti-TCR mAb.
Role of the membrane proximal region in Lselectin down-modulation
We and others previously demonstrated that the deletion of an extended sequence of amino acids from the membrane proximal region of Lselectin rendered the molecule resistant to PMAinduced proteolysis (18, 20, 21) . We also showed that a PMA-resistant L-selectin mutant (32Ide1.9) lacking a nine-residue sequence from this region could be down-modulated from transfected cells by exposure to an immobilized anti-L-selectin antibody (18) . To determine if this PMA-resistant mutant could be down-modulated by other crosslinking ligands, L1.2 cells were transfected with WT L-selectin and the 32Ide1.9 mutant cDNAs. Transfectants were exposed to PMA (50 u.g/ml), sulfatides (l0 u.g/ml) or an immobilized anti-Lselectin antibody (Dreg 200 at 10 u.g/ml) for I hour in the presence or absence ofTAPI (25 nM). The transfected cells were then analyzed by flow cytometry for L-selectin expression using the noncross reactive FITC-conjugated anti-L-selectin mAb Dreg 56. As shown in Figure 2, Fluorescence Intensity Cell Number WT L-selectin from the transfected L1.2 cells but had no effect on that induced by the anti-L-selectin mAb or sulfatides. The 321del.9 mutant was also down-modulated in response to cross-linking ligands, despite its resistance to PMA (Fig. 3) . Furthermore, as with WT L-selectin, the downmodulation of 321del.9 induced by cross-linking with the anti-L-selectin antibody or sulfatides was not prevented by TAPI.
Role ofthe cytoplasmic tail in L-selectin downmodulation
The cytoplasmic tail ofL-selectin is essential for its adhesive function but not for PMA-induced shedding (20, 22) . To determine if it might be needed for down-modulation induced by crosslinking, L1.2 cells were transfected with an Lselectin mutant lacking 15 of the 17 residues in the cytoplasmic tail (344del.I5). The transfectants were exposed to PMA (50 ng/ml), sulfatides (10 /-Lg/ml), or an immobilized anti-L-selectin antibody (Dreg 200 at 10 /-Lg/ml) for 1 hour in the presence or absence ofTAPI (25 nM) and then analyzed by flow cytometry for L-selectin expression with FITC-conjugated anti-L-selectin mAb Dreg 56. As shown in Figure 4 , the 344del.15 mutant was down-modulated in response to PMA or sulfatides but not in response to cross-linking with Dreg 200. As with WT L-selectin, the PMA-induced down-modulation of the 344del.15 mutant was inhibited by TAPI, but not that induced by sulfatides. Fig. 5A ) and is clearly not full length. Flow cytometric analysis showed a corresponding loss of L-selectin from the cell surface on PMA, mAb and sulfatide treatment, whereas control cells retained surface L-selectin (Fig.5B) 17.3 17.8
Sulfatide exposed to various L-selectin ligands is a proteolytic fragment similar, ifnot identical, to that shed from the cell surface in response to PMA. DISCUSSION L-selectin is shed from the surface of leukocytes in response to activating stimuli through the action of TACE, the metalloprotease recently implicated in the shedding of TNF-<X, the two TNF receptors, and a number of other surface molecules (23) . The high concentration of L-selectin in the circulation of even healthy humans (2 f,Lg/ml)(11), however, suggests that leukocyte activation by an exogenous stimulus may not be necessary for the shedding of the molecule. Indeed, we and others have shown that simple ligand engagement, as may occur during normal leukocyte trafficking, downmodulates L-selectin (8, 18, 24) . Ligand binding to L-selectin results in the shedding of TNF receptors from neutrophils (25) , suggesting that TACE may be activated in these cells through L-selectin engagement. However, we have shown that ligand-induced L-selectin down-modulation from lymphocytes is resistant to TAPI and occurs despite the deletion of the putative TACE cleavage site from the membrane proximal region. These results suggest that TACE activity may not be involved in ligand-induced L-selectin downmodulation from lymphocytes nor account for the bulk of the L-selectin present in plasma.
The biochemical basis for ligand-induced L-selectin down-modulation is unclear. It is presumably PKC-independent since it is unaffected by staurosporine at concentrations that completely block PMA-induced shedding (18) . Furthermore, in contrast to PMA-induced shedding, that induced by L-selectin ligands is not associated with upregulation of CD25 or CD69 (data not shown). We have shown that the cytoplasmic tail of Lselectin is required for anti-L-selectin antibodyinduced down-modulation. This suggests that the process may be activated through the physical association of L-selectin with the cytoskeleton (26) or other cytoplasmic proteins to which it is known to bind such as calmodulin (27) . This dependency on the cytoplasmic domain is of some interest given the fact that this domain plays no role in PMA-induced shedding (20) . Ligand engagement of L-selectin results in the activation of p56 1c k, ras, and several downstream signaling pathways (28, 29) . Frey et. al. recently showed that antibody-induced L-selectin downmodulation can be blocked by the tyrosine kinase inhibitor genestein (24) . The requirement for the cytoplasmic tail and the susceptibility to inhibition by genestein indicate that antibody-induced Lselectin down-modulation is dependent on the activity of an as yet undetermined tyrosine kinase and the association of L-selectin with the cytoplasm.
Our results show that L-selectin is downmodulated in response to glycomimetic ligands such as sulfatides. This down-modulation is not an artifact attributable to epitope masking as sulfatides bind an epitope distinct from the Dreg 56 binding site (30) (31) (32) (33) . In contrast to the downmodulation ofL-selectin induced by the Dreg 200 antibody, that induced by exposure to the ligand, sulfatide, is not prevented by deleting the cytoplasmic tail. This observation suggests that these ligands may interact with alternative surface receptors in addition to L-selectin which are capable of inducing L-selectin down regulation. Sulfatides have, in fact, been shown to bind to a 65 kD receptor distinct from L-selectin and to trigger an increase in cytosolic calcium and lymphocyte aggregation (34) . In light of this observation, it is possible that the increase in cytosolic calcium, the enhanced expression ofTNF and IL-8 mRNA, and increased tyrosine kinase activity previously demonstrated in sulfatide-treated neutrophils (35) may not be entirely mediated through L-selectin. To the extent that sulfatides are able to activate the above signaling pathways independent of their binding to L-selectin, one might predict that these ligands would down-modulate an L-selectin mutant unable to associate with the cytoskeleton as this particular mutant is readily shed in response to other activating stimuli such as PMA treatment (20) . The signaling pathway(s) activated by sulfatides that is responsible for L-selectin downmodulation is presumably distinct from that activated by PMA, since unlike PMA-induced shedding, the down-modulation of L-selectin induced by these ligands is unaffected by TAPI or the deletion of residues at the TACE cleavage site.
The down-modulation of L-selectin from Jurkat T cells exposed to an anti-TCR antibody is only partially blocked by TAPI, suggesting that it may be in part TACE-independent. Two independent studies, one using fluorescence energy transfer (FET) (36) and the other using coimmunoprecipitation and immunoblotting analysis (37) demonstrated that L-selectin associates with the TCR/CD3 complex. TCR engagement results in internalization of receptor components (38) and since L-selectin is associated with the TCR, it is possible that a portion ofL-selectin is internalized along with the TCR in response to the WT31 antibody. Studies to assess this possibility are underway.
The mechanism by which exposure to sulfatides or L-selectin antibodies results in the disappearance of L-selectin from the cell surface is unclear. Lselectin can be detected in the supernatants of antibody-treated lymphocytes by enzyme-linked immunosorbent assay (ELISA) (24) . This finding rules out internalization as the predominant mechanism by which L-selectin is down-modulated by ligand exposure. However, it does not necessarily indicate that L-selectin is proteolytically cleaved from the cell surface since the shedding of membrane vesicles derived from microvilli and containing intact L-selectin could account for its disapearance from the cell surface and its detection in lymphocyte supernatants by ELISA. Our observation that the material immunoprecipitated from the supernatants of antibody-treated Jurkat cells is of the same size as the L-selectin fragment detected after PMA treatment is the first evidence clearly demonstrating that ligand-induced downregulation of L-selectin involves a protease. The fact that ligand-induced L-selectin down-modulation is TAPI-resistant suggests that the responsible protease might not be TACE, the hydroxamatesensitive metalloprotease thought to mediate PMAinduced L-selectin shedding.
Our studies indicate that L-selectin can be down-modulated from the cell surface through the activation of a PMA-responsive, TACEdependent signaling pathway, a ligand-activated, TACE-independent process that requires a physical association between L-selectin and the cytoplasm, a distinct third TAPI -resistant pathway mediated through putative alternative sulfatide receptor, and perhaps other signaling pathways. The variable effects of TACE inhibitors and structural mutations on L-selectin downmodulation induced by these diverse pathways require caution in the design and interpretation of studies investigating the role of L-selectin shedding in physiological events such as leukocyte extravasation.
